Literature DB >> 15517490

Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.

Geoffrey B Thompson1, Ian D Hay.   

Abstract

Childhood papillary thyroid carcinoma is associated with more locally aggressive and more frequent distant disease than its adult counterpart. Recurrence rates tend to be higher in children, but cause-specific mortality remains low. Optimal initial treatment of childhood papillary thyroid carcinoma should include total or near-total thyroidectomy and central compartment node clearance. Modified neck dissections should be performed for biopsy-proven lateral neck disease. Every effort should be made to maintain parathyroid and laryngeal nerve function. Radical neck dissections are to be avoided. Radioiodine remnant ablation (RRA), appropriate thyroid hormone suppressive therapy (THST), and judicious use of therapeutic doses of (131)I are applied to achieve a disease-free status, which is most often confirmed by negative neck ultrasonography, negative whole-body scan (either withdrawal or recombinant human thyroid-stimulating hormone-stimulated), and extremely low levels of serum thyroglobulin. Appropriate utilization of (131)I, THST, repeat surgery, external beam radiotherapy, and rarely chemotherapy may provide long-term palliation and some cures in patients with recurrent/persistent disease. Follow-up should be lifelong, and the care of children after age 17 should subsequently be transferred to adult-care endocrinologists with expertise in managing thyroid neoplasia. Optimal surgical management can be achieved if adequate operations are routinely carried out by "high-volume" thyroid surgeons with expertise in the care of children. Nowhere is a multidisciplinary approach (endocrinologists, surgeons, nuclear medicine physicians, pediatricians, pathologists, oncologists) more critical than in the long-term management of papillary thyroid carcinoma that presents during childhood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517490     DOI: 10.1007/s00268-004-7605-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  119 in total

Review 1.  Radiation exposure associated with imaging of the chest: comparison of different radiographic and computed tomography techniques.

Authors:  S Diederich; H Lenzen
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

2.  AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

Authors:  R H Cobin; H Gharib; D A Bergman; O H Clark; D S Cooper; G H Daniels; R A Dickey; D S Duick; J R Garber; I D Hay; J S Kukora; H M Lando; A B Schorr; M A Zeiger
Journal:  Endocr Pract       Date:  2001 May-Jun       Impact factor: 3.443

Review 3.  Health effects of the Chernobyl accident: fears, rumours and the truth.

Authors:  Mati Rahu
Journal:  Eur J Cancer       Date:  2003-02       Impact factor: 9.162

Review 4.  Thyroid cancer in childhood.

Authors:  J B Gorlin; S E Sallan
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

5.  Differentiated thyroid cancer in children and adolescents.

Authors:  D Giuffrida; C Scollo; G Pellegriti; G Lavenia; M P Iurato; V Pezzin; A Belfiore
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 6.  Thyroid cancer: a lethal endocrine neoplasm.

Authors:  J Robbins; M J Merino; J D Boice; E Ron; K B Ain; H R Alexander; J A Norton; J Reynolds
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

7.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.

Authors:  C A Welch Dinauer; R M Tuttle; D K Robie; D R McClellan; R L Svec; C Adair; G L Francis
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

Review 8.  Cancer of the thyroid gland in infants and children.

Authors:  M A Skinner
Journal:  Semin Pediatr Surg       Date:  2001-08       Impact factor: 2.754

9.  Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.

Authors:  D Van Nostrand; J Neutze; F Atkins
Journal:  J Nucl Med       Date:  1986-10       Impact factor: 10.057

Review 10.  Diagnosis of thyroid nodules by fine needle biopsy: use and abuse.

Authors:  J I Hamburger
Journal:  J Clin Endocrinol Metab       Date:  1994-08       Impact factor: 5.958

View more
  16 in total

1.  Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.

Authors:  Ning Qu; Ling Zhang; Zhong-Wu Lu; Qing-Hai Ji; Shu-Wen Yang; Wen-Jun Wei; Yan Zhang
Journal:  Tumour Biol       Date:  2015-12-22

2.  Pediatric thyroid cancers: an Indian perspective.

Authors:  Devendra A Chaukar; Abhishek D Vaidya
Journal:  Indian J Surg Oncol       Date:  2012-02-16

Review 3.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

Review 4.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

5.  Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients.

Authors:  Samuel Golpanian; Eduardo A Perez; Jun Tashiro; John I Lew; Juan E Sola; Anthony R Hogan
Journal:  Pediatr Surg Int       Date:  2015-12-30       Impact factor: 1.827

6.  Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics.

Authors:  Kiminori Sugino; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Takashi Uruno; Akifumi Suzuki; Junko Akaishi; Chie Masaki; Ken-ichi Matsuzu; Koichi Ito
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

7.  Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.

Authors:  Ian D Hay; Tomas Gonzalez-Losada; Megan S Reinalda; Jennifer A Honetschlager; Melanie L Richards; Geoffrey B Thompson
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

8.  Differentiated thyroid carcinoma: comparison of histopathologic characteristics, clinical course, and outcome between young children and adolescents.

Authors:  M Motazedian; B Shafiei; P Vatankhah; S Hoseinzadeh; M Mirzababaee; L Fathollahi; M Ansari; N Baharfar; F Tabeie; I Neshandar Asli
Journal:  Med Oncol       Date:  2013-02-20       Impact factor: 3.064

9.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

10.  Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.

Authors:  C Spinelli; F Tognetti; S Strambi; R Morganti; M Massimino; P Collini
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.